Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study

(2022) Nicole Wolter et al.   LANCET

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

(2022) Raquel Viana et al.   NATURE

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

(2022) Yunlong Cao et al.   NATURE

SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron

(2022) Syed Faraz Ahmed et al.   Viruses-Basel

Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario

(2022) Sharifa Nasreen et al.   Nature Microbiology

Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine

(2022) Yihao Liu et al.   Cell Discovery

Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant

(2022) Maren Schubert et al.   BMC Medicine

Comparative Effectiveness of mRNA and Inactivated Whole Virus Vaccines against COVID-19 Infection and Severe Disease in Singapore

(2022) M Premikha et al.   CLINICAL INFECTIOUS DISEASES

Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic

(2022) Xinxin Zhang et al.   LANCET

Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2

(2022) Ryuta Uraki et al.   NATURE

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant

(2022) Nick Andrews et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants

(2022) Jingyou Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Omicron variant Spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccines

(2022) Yannic C. Bartsch et al.   Science Translational Medicine

Comparative vaccine effectiveness against severe COVID-19 over time in US hospital administrative data: a case-control study

(2022) Bill J Wright et al.   Lancet Respiratory Medicine

Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study

(2022) Martina E McMenamin et al.   LANCET INFECTIOUS DISEASES

Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil

(2022) Otavio T. Ranzani et al.   Nature Communications

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

(2021) Noa Dagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

(2021) Eric J Haas et al.   LANCET

Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults

(2021) Nawal Al Kaabi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar

(2021) Hiam Chemaitelly et al.   NATURE MEDICINE

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

(2021) Alejandro Jara et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness of an Inactivated SARS-CoV-2 Vaccine

(2021) Annelies Wilder-Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study

(2021) Otavio T Ranzani et al.   BMJ-British Medical Journal

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization

(2021) Dennis Lapuente et al.   Nature Communications